Pawlas J, Vedsø P, Jakobsen P, Huusfeldt P O, Begtrup M
Department of Medicinal Chemistry, The Royal Danish School of Pharmacy, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
J Org Chem. 2000 Dec 29;65(26):9001-6. doi: 10.1021/jo000986v.
1-Hydroxypyrazolo[3,4-c]quinoline (22), 1-hydroxypyrazolo[4, 3-c]quinoline (21), 1-hydroxypyrazolo[3,4-c]isoquinoline (20), and 1-hydroxypyrazolo[4,3-c]isoquinoline (19) were prepared from 1-benzyloxypyrazole (6), establishing the pyridine B-ring in the terminal step. The pyridine ring of pyrazoloquinolines 14 and 18 was formed via cyclization of a formyl group at C-4 or C-5 and an amino group of a 2-aminophenyl substituent at C-5 or C-4 in 1-benzyloxypyrazole. The pyridine ring of pyrazoloisoquinolines 5 and 9 was created via cyclization of a formyl group in a 2-formylphenyl substituent at C-4 or C-5 with an iminophosphorane group installed at C-5 or C-4 of 1-benzyloxypyrazole by lithiation followed by reaction with tosyl azide and then with tributylphoshine utilizing the Staudinger/aza-Wittig protocol. The 2-aminophenyl and the 2-formylphenyl substituent were introduced at C-5 or C-4 by regioselective metalation followed by transmetalation to the pyrazolylzinc halide and subsequent palladium-catalyzed cross-coupling with 2-iodoaniline or 2-bromobenzaldehyde. The order of reactions and use of protecting groups in the individual sequences have been optimized. The 1-benzyloxy-substituted pyrazoloquinolines and isoquinolines thus obtained were debenzylated by strong acid to the corresponding 1-hydroxy-substituted pyrazoloquinolines and isoquinolines 19-22.
1-羟基吡唑并[3,4-c]喹啉(22)、1-羟基吡唑并[4,3-c]喹啉(21)、1-羟基吡唑并[3,4-c]异喹啉(20)和1-羟基吡唑并[4,3-c]异喹啉(19)由1-苄氧基吡唑(6)制备,在最后一步构建吡啶B环。吡唑并喹啉14和18的吡啶环是通过1-苄氧基吡唑中C-4或C-5处的甲酰基与C-5或C-4处2-氨基苯基取代基的氨基环化形成的。吡唑并异喹啉5和9的吡啶环是通过1-苄氧基吡唑C-5或C-4处安装的亚氨基膦基团与C-4或C-5处2-甲酰基苯基取代基中的甲酰基环化形成的,先通过锂化,然后与对甲苯磺酰叠氮反应,再利用施陶丁格/氮杂维蒂希反应历程与三丁基膦反应。通过区域选择性金属化,然后将其转金属化为吡唑基卤化锌,随后与2-碘苯胺或2-溴苯甲醛进行钯催化的交叉偶联,在C-5或C-4处引入2-氨基苯基和2-甲酰基苯基取代基。对各个反应序列中反应的顺序和保护基团的使用进行了优化。由此得到的1-苄氧基取代的吡唑并喹啉和异喹啉用强酸脱苄基,得到相应的1-羟基取代的吡唑并喹啉和异喹啉19 - 22。